Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Christof Burek"'
Autor:
Andreas Rosenwald, Peter Rieckmann, Christof Burek, Matthias Eck, Anthony P. Moran, Hans Konrad Müller-Hermelink, S. Endrich, D. Beier, B. Schmaußer
Publikováno v:
Clinical and Experimental Immunology. 152:88-94
Summary In Helicobacter pylori gastritis gastric epithelium plays a central role in the innate immunity to H. pylori. However, epithelial receptors interacting with H. pylori have been poorly characterized so far. Recently a new triggering receptor e
Autor:
Thorsten Stiewe, Anne Catherine Bretz, Christof Burek, Rasa Beinoraviciute-Kellner, Michaela Beitzinger, Gregory S. Harms, Andreas Rosenwald, Markus Sauer
Publikováno v:
Nucleic Acids Research
The p53 family is known as a family of transcription factors with functions in tumor suppression and development. Whereas the central DNA-binding domain is highly conserved among the three family members p53, p63 and p73, the C-terminal domains (CTDs
Publikováno v:
APMIS. 115:1135-1146
Gene expression profiling is a powerful tool to uncover complex molecular networks in cancer and, specifically, in malignant lymphomas. Within diffuse large B-cell lymphomas (DLBCL), two major molecular subtypes, the activated B-cell-like (ABC) and t
Autor:
Philipp Ströbel, M Lahti, Ralf Gold, Christof Burek, K.V. Toyka, Berthold Schalke, Nick Willcox, Peter Rieckmann, Astrid Murumägi, Hans Konrad Müller-Hermelink, Anthony Meager, Pärt Peterson, Alexander Marx, Wilfried Nix, Reinhild Klein, R Pujoll‐Borrell, Kai Krohn, M Luster, Andreas Rosenwald
Publikováno v:
The Journal of Pathology. 211:563-571
Thymomas are thymic epithelial neoplasms, associated with a variety of autoimmune disorders (especially myasthenia gravis), that apparently result from aberrant intra-tumourous thymopoiesis and export of inefficiently tolerized T-cells to the periphe
Publikováno v:
Der Onkologe. 12:603-611
Die WHO-Klassifikation der malignen Lymphome beschreibt klinisch-pathologische Lymphomentitaten und berucksichtigt dabei morphologische, immunologische, genetische und klinische Gesichtspunkte. Diffuse groszellige B-Zell-Lymphome (DLBCL) stellen eine
Autor:
T. C. Greiner, Andreas Rosenwald, E. S. Jaffe, Montserrat E, Xavier Puig, Liming Yang, Joseph M. Connors, Jan Delabie, Itziar Salaverria, Christof Burek, Rita M. Braziel, James O. Armitage, George Wright, Wing C. Chan, Wyndham Wilson, Thomas M. Grogan, Philipp Jehn, Louis M. Staudt, H.K. Müller-Hermelink, Victor Moreno, Armando López-Guillermo, Sílvia Beà, Elias Campo, Richard I. Fisher, Harald Holte, Stein Kvaløy, John Powell, Dennis D. Weisenburger, Andreas Zettl, Erlend B. Smeland, Randy D. Gascoyne, German Ott, Simon Rm
Publikováno v:
Blood. 106:3183-3190
Gene-expression profiling has identified 3 major subgroups of diffuse large B-cell lymphoma (DLBCL): germinal center B-cell-like (GCB), activated B-cell-like (ABC), and primary mediastinal DLBCL (PMBCL). Using comparative genomic hybridization (CGH),
Autor:
Alexander Marx, O. Elert, Christof Burek, Peter Rieckmann, Andreas Rosenwald, Wilfred Nix, Hans Konrad Müller-Hermelink, Thomas Kerkau, Pärt Peterson, Astrid Murumägi, Niklas Beyersdorf, Vera Hummel, Berthold Schalke, Philipp Ströbel, Reinhard Kiefer, Niko Sillanpää
Publikováno v:
Annals of Neurology. 56:901-904
Myasthenia gravis (MG) is the prime autoimmune manifestation of thymomas. We investigated the generation of T cells with a regulatory phenotype (T(R)) in thymomas with and without associated MG. In patients with MG(+) thymomas, maturation and export
Publikováno v:
Nucleic Acids Research. 29:423-429
Termination of murine rDNA transcription by RNA polymerase I (Pol I) requires pausing of Pol I by terminator-bound TTF-I (transcription termination factor for Pol I), followed by dissociation of the ternary complex by PTRF (Pol I and transcript relea
Autor:
Jeremy Hamon, Bas J. Blaauboer, Silke Ruzek, Donatella Carpi, Walter Pfaller, Christian G. Huber, Christof Burek, Martin O. Leonard, Anja Wilmes, Wolfgang Dekant, Alice Limonciel, Patricia Bellwon, Arno Lukas, Olga Schmal, Lydia Aschauer, Emanuela Testai, Germaine L. Truisi, Frédéric Y. Bois, Konrad Moenks, Claude Guillou, Andreas Handler, Stefan O. Mueller, Chris Bielow, Paul Jennings, Emma Di Consiglio, Karin Herrgen, Philip G. Hewitt
Publikováno v:
Journal of Proteomics; Vol 79
Journal of Proteomics
Journal of Proteomics, Elsevier, 2013, 79, pp.180-194. ⟨10.1016/j.jprot.2012.11.022⟩
Journal of Proteomics
Journal of Proteomics, Elsevier, 2013, 79, pp.180-194. ⟨10.1016/j.jprot.2012.11.022⟩
International audience; High content omic techniques in combination with stable human in vitro cell culture systems have the potential to improve on current pre-clinical safety regimes by providing detailed mechanistic information of altered cellular
Autor:
Lars Hofmann, Markus Sauer, Thorsten Stiewe, Claudia Oswald, Christof Burek, Rasa Beinoraviciute-Kellner, H Griesmann, Michaela Beitzinger, Anne Catherine Bretz, Andreas Rosenwald
p53 is known to prevent tumour formation by restricting the proliferation of damaged or oncogene-expressing cells. In contrast, how the p53 family member p73 suppresses tumour formation remains elusive. Using a step-wise transformation protocol for h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b1e86d810762930a40afbf3784f3240
https://europepmc.org/articles/PMC2265751/
https://europepmc.org/articles/PMC2265751/